Safety and Efficacy of Sequential Adjuvant AI Therapy in ER Positive Breast Cancer
Long-term follow-up of efficacy and toxicity outcomes from the IES study of adjuvant aromatase inhibitor therapy in postmenopausal estrogen receptor positive breast cancer